Cannabis should be made available to treat a limited number of medical conditions, despite the lack of evidence for its effectiveness and safety, a Government-commissioned review has recommended.
Minister for Health Simon Harris will on Friday publish the Health Products Regulatory Authority (HPRA) report on cannabis for medical use.
He will also announce plans for “a compassionate access programme for cannabis-based treatments”.
Medicinal cannabis could be provided to specific categories of patients with multiple sclerosis, severe epilepsy and those suffering intractable nausea and vomiting associated with chemotherapy, according to the recommendation of the expert working group.
“Access to medicinal cannabis is ultimately a societal and policy decision which has to balance the lack of scientific evidence against patient-led demand,” the report by the group said.
Prof Tony O’Brien, chairman of the group, said it is pleased to “cautiously advise” for the restricted use of cannabis products for a limited number of medical conditions.
If a policy …